The Association Between Primary Source of Healthcare Coverage and Colorectal Cancer Screening Among US Veterans

Digestive Diseases and Sciences

Volumn 62, Issue 8, 2017, Pages 1923-1932

  May, Folasade P ^a,b   Yano, Elizabeth M ^a,c   Provenzale, Dawn ^d,e,f   Neil Steers, W ^a,b   Washington, Donna L ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Colorectal cancer; Disparities; Prevention; Screening; Veterans Affairs

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BLACK PERSON; CANCER SCREENING; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; FEMALE; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIED PERSON; OUTCOME ASSESSMENT; PREDICTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SIGMOIDOSCOPY; TELEPHONE INTERVIEW; UNITED STATES; VETERAN; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; GOVERNMENT; INSURANCE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VETERANS HEALTH;

AGED; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INSURANCE COVERAGE; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS; VETERANS HEALTH;

EID: 85019572613     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-017-4607-x     Document Type: Article

References (49)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117.
2. ACS: American Cancer Society. Colorectal Cancer Facts and Figures 2014–2016. Atlanta: American Cancer Society; 2014.
3. Ransohoff DF, Sox HC. Clinical practice guidelines for colorectal cancer screening: new recommendations and new challenges. JAMA. 2016;315:2529–2531.
4. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434–437.
5. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.
6. Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106–1114.
7. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674–1680.
8. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471.
9. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–1633.
10. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial—SCORE. J Natl Cancer Inst. 2011;103:1310–1322.
11. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095–1105.
12. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.
13. USPSTF. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627–637.
14. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345–2357.
15. Centers for Disease C. Prevention: Vital signs: colorectal cancer screening test use—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:881–888.
16. Modiri A, Makipour K, Gomez J, Friedenberg F. Predictors of colorectal cancer testing using the California Health Inventory Survey. World J Gastroenterol. 2013;19:1247–1255.
17. May FP, Almario CV, Ponce N, Spiegel BM. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening. Am J Gastroenterol. 2015;110:1388–1394.
18. Walsh JM, Posner SF, Perez-Stable EJ. Colon cancer screening in the ambulatory setting. Prev Med. 2002;35:209–218.
19. Trivers KF, Shaw KM, Sabatino SA, Shapiro JA, Coates RJ. Trends in colorectal cancer screening disparities in people aged 50–64 years, 2000–2005. Am J Prev Med. 2008;35:185–193.
20. Emmons KM, Lobb R, Puleo E, Bennett G, Stoffel E, Syngal S. Colorectal cancer screening: prevalence among low-income groups with health insurance. Health Aff (Millwood). 2009;28:169–177.
21. Jackson CS, Oman M, Patel AM, Vega KJ. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol. 2016;7:S32–S43.
22. Long MD, Lance T, Robertson D, Kahwati L, Kinsinger L, Fisher DA. Colorectal cancer testing in the national Veterans Health Administration. Dig Dis Sci. 2012;57:288–293.
23. VA Office of Public nd Intergovernmental Affairs (2016). VA Lauded by National Colorectal Cancer Roundtable for Screening Rates. Retrieved December 1, 2016 from https://www.va.gov/opa/pressrel/pressrelease.cfm?id=2835#sthash.vfj4aLHy.dpuf.
24. Pierannunzi CTM, Garvin W, Shaw F, Balluz L. Methodological changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR. 2012;61:410–413. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6122a3.htm. Accessed September 1, 2016.
25. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta: GUSDoHaHS, Centers for Disease Control and Prevention; 2014.
26. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta: GUSDoHaHS, Centers for Disease Control and Prevention; 2014.
27. US Preventive Services Task Force. USPSTF A–Z topic guide website. http://www.uspreventiveservicestaskforce.org/uspstopics.htm. Accessed August.
28. National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control. BRFSS Statistical Brief on Cancer Screening Questions. Retrieved July 20, 2016 from http://www.cdc.gov/brfss/data_documentation/pdf/2014_brfss-statistical-brief_cancer.pdf.
29. Bromley EG, May FP, Federer L, Spiegel BM, van Oijen MG. A systematic review of patient, provider, and system barriers to colorectal cancer screening with colonoscopy in African–Americans. Gastroenterology. 2013;144:S581.
30. May FP, Bromley EG, Reid MW, et al. Low uptake of colorectal cancer screening among African Americans in an integrated Veterans Affairs health care network. Gastrointest Endosc. 2014;80:291–298
31. Bastani R, Glenn BA, Taylor VM, et al. Integrating theory into community interventions to reduce liver cancer disparities: the health behavior framework. Prev Med. 2010;50:63–67.
32. Pucheril D, Sammon JD, Sood A, et al. Contemporary nationwide patterns of self-reported prostate-specific antigen screening in US veterans. Urol Oncol. 2015;33:e507–e515.
33. Ross JS, Keyhani S, Keenan PS, et al. Use of recommended ambulatory care services: is the Veterans Affairs quality gap narrowing? Arch Intern Med. 2008;168:950–958.
34. Fedewa SA, Ma J, Sauer AG, et al. How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018? Cancer. 2015;121:4258–4265.
35. Coronado GD, Retecki S, Schneider J, Taplin SH, Burdick T, Green BB. Recruiting community health centers into pragmatic research: findings from STOP CRC. Clin Trials. 2016;13:214–222.
36. Partin MR, Noorbaloochi S, Grill J, et al. The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening adherence. Cancer Causes Control. 2010;21:1357–1368.
37. Helfrich CD, Sylling PW, Gale RC, et al. The facilitators and barriers associated with implementation of a patient-centered medical home in VHA. Implement Sci. 2016;11:24.
38. Breland JY, Asch SM, Slightam C, Wong A, Zulman DM. Key ingredients for implementing intensive outpatient programs within patient-centered medical homes: a literature review and qualitative analysis. Healthc (Amst). 2016;4:22–29.
39. Chao HH, Schwartz AR, Hersh J, et al. Improving colorectal cancer screening and care in the Veterans Affairs Healthcare System. Clin Colorectal Cancer. 2009;8:22–28.
40. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.
41. Saha S, Freeman M, Toure J, Tippens KM, Weeks C, Ibrahim S. Racial and ethnic disparities in the VA health care system: a systematic review. J Gen Intern Med. 2008;23:654–671.
42. Dolan NC, Ferreira MR, Davis TC, et al. Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol. 2004;22:2617–2622.
43. Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC. Centers for Disease C, Prevention: Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. MMWR Suppl. 2011;60:42–46.
44. Doubeni CA, Laiyemo AO, Young AC, et al. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med. 2010;8:299–307.
45. May FP, Almario CV, Ponce N, Spiegel BM. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening. Am J Gastroenterol. 2015;110:1388–1394.
46. Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006;30:313–319.
47. Koepsell T, Reiber G, Simmons KW. Behavioral risk factors and use of preventive services among veterans in Washington State. Prev Med. 2002;35:557–562.
48. Reiber GE, Koepsell TD, Maynard C, Haas LB, Boyko EJ. Diabetes in nonveterans, veterans, and veterans receiving Department of Veterans Affairs Health Care. Diabetes Care. 2004;27:B3–B9.
49. Agency TDH. Evaluation of the TRICARE Program: access, cost, and quality; Fiscal Year 2015 Report to Congress. Falls Church, VA.